340 related articles for article (PubMed ID: 26520757)
1. A feasibility study: Selection of a personalized radiotherapy fractionation schedule using spatiotemporal optimization.
Kim M; Stewart RD; Phillips MH
Med Phys; 2015 Nov; 42(11):6671-8. PubMed ID: 26520757
[TBL] [Abstract][Full Text] [Related]
2. A feasibility study of dynamic adaptive radiotherapy for nonsmall cell lung cancer.
Kim M; Phillips MH
Med Phys; 2016 May; 43(5):2153. PubMed ID: 27147327
[TBL] [Abstract][Full Text] [Related]
3. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
[TBL] [Abstract][Full Text] [Related]
4. A feasibility study of spatiotemporally integrated radiotherapy using the LQ model.
Kim M; Phillips MH
Phys Med Biol; 2018 Dec; 63(24):245016. PubMed ID: 30523816
[TBL] [Abstract][Full Text] [Related]
5. Individualized dose prescription for hypofractionation in advanced non-small-cell lung cancer radiotherapy: an in silico trial.
Hoffmann AL; Troost EG; Huizenga H; Kaanders JH; Bussink J
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1596-602. PubMed ID: 22245206
[TBL] [Abstract][Full Text] [Related]
6. A novel dose-volume metric for optimizing therapeutic ratio through fractionation: retrospective analysis of lung cancer treatments.
Keller H; Hope A; Meier G; Davison M
Med Phys; 2013 Aug; 40(8):084101. PubMed ID: 23927363
[TBL] [Abstract][Full Text] [Related]
7. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
9. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy.
Nakamura A; Shibuya K; Nakamura M; Matsuo Y; Shiinoki T; Nakata M; Mizowaki T; Hiraoka M
Med Phys; 2013 Feb; 40(2):021701. PubMed ID: 23387724
[TBL] [Abstract][Full Text] [Related]
10. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of flattened and unflattened beams for stereotactic ablative radiotherapy of stage I non-small cell lung cancer.
Hrbacek J; Lang S; Graydon SN; Klöck S; Riesterer O
Med Phys; 2014 Mar; 41(3):031709. PubMed ID: 24593713
[TBL] [Abstract][Full Text] [Related]
12. Optimization of leaf margins for lung stereotactic body radiotherapy using a flattening filter-free beam.
Wakai N; Sumida I; Otani Y; Suzuki O; Seo Y; Isohashi F; Yoshioka Y; Hasegawa M; Ogawa K
Med Phys; 2015 May; 42(5):2125-31. PubMed ID: 25979007
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
[TBL] [Abstract][Full Text] [Related]
14. Semiautomated head-and-neck IMRT planning using dose warping and scaling to robustly adapt plans in a knowledge database containing potentially suboptimal plans.
Schmidt M; Lo JY; Grzetic S; Lutzky C; Brizel DM; Das SK
Med Phys; 2015 Aug; 42(8):4428-34. PubMed ID: 26233173
[TBL] [Abstract][Full Text] [Related]
15. The theoretical benefit of beam fringe compensation and field size reduction for iso-normal tissue complication probability dose escalation in radiotherapy of lung cancer.
Engelsman M; Remeijer P; van Herk M; Mijnheer B; Damen E
Med Phys; 2003 Jun; 30(6):1086-95. PubMed ID: 12852532
[TBL] [Abstract][Full Text] [Related]
16. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
17. Adaptive stereotactic body radiation therapy planning for lung cancer.
Qin Y; Zhang F; Yoo DS; Kelsey CR; Yin FF; Cai J
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):209-15. PubMed ID: 23790773
[TBL] [Abstract][Full Text] [Related]
18. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
[TBL] [Abstract][Full Text] [Related]
19. Comparison of direct machine parameter optimization versus fluence optimization with sequential sequencing in IMRT of hypopharyngeal carcinoma.
Dobler B; Pohl F; Bogner L; Koelbl O
Radiat Oncol; 2007 Sep; 2():33. PubMed ID: 17822529
[TBL] [Abstract][Full Text] [Related]
20. Dose-shaping using targeted sparse optimization.
Sayre GA; Ruan D
Med Phys; 2013 Jul; 40(7):071711. PubMed ID: 23822415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
